STING agonist-1
CAS No. 702662-50-8
STING agonist-1( G10 )
Catalog No. M21625 CAS No. 702662-50-8
STING agonist-1 is a human-specific STING agonistelicits antiviral activity against emerging Alphaviruses.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 67 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 179 | In Stock |
|
| 50MG | 291 | In Stock |
|
| 100MG | 436 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSTING agonist-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionSTING agonist-1 is a human-specific STING agonistelicits antiviral activity against emerging Alphaviruses.
-
DescriptionSTING agonist-1 is a human-specific STING agonistelicits antiviral activity against emerging Alphaviruses.
-
In VitroG10 induces IFN/IRF3- but not NF-κB-dependent transcription in human fibroblasts.G10 is an indirect activator of human STING-dependent phenotypes.G10-mediated IRF3 activation and anti-Alphaviral activity occur independently of IPS-1/MAVS-dependent signaling.STING is required for G10-mediated IRF3 activation, gene expression, and anti-Alphaviral activity.G10 induces STING-dependent synthesis and secretion of bioactive interferon.G10 induces innate antiviral mRNA expression in primary human cells.
-
In Vivo——
-
SynonymsG10
-
PathwayImmunology/Inflammation
-
TargetSTING
-
RecptorSTING
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number702662-50-8
-
Formula Weight430.88
-
Molecular FormulaC21H16ClFN2O3S
-
Purity>98% (HPLC)
-
SolubilityDMSO:100 mg/mL (232.08 mM; Need ultrasonic)
-
SMILESFc1cccc(Cl)c1CN1C(=O)CSc2ccc(cc12)C(=O)NCc1ccco1
-
Chemical Name4-(2-Chloro-6-fluorobenzyl)-N-(furan-2-ylmethyl)-3-oxo-34-dihydro-2H-benzo[b][14]thiazine-6-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
MSA-2
MSA-2, a potent and orally available non-nucleotide STING agonist, has EC50s of 8.3 and 24 μM for human STING isoforms WT and HAQ, respectively. MSA-2 shows antitumor activity and stimulates interferon-β secretion in tumors, induces tumor regression with durable antitumor immunity, and synergizes with anti-PD-1 in syngeneic mouse tumor models.
-
SR-717
SR-717 is a non-nucleotide STING agonist with EC50s of 2.1 μM and 2.2 μM in ISG-THP1 (WT) and ISG-THP1 cGAS KO (cGAS KO) cell lines, respectively.
-
ADU-S100
ADU-S100 (MIW815) is a synthetic cyclic dinucleotide agonist of STING, elicits potent and durable anti-tumor immunity when administered IT in pre-clinical syngeneic tumor models.
Cart
sales@molnova.com